Treatment decisions in oncology are commonly informed by the visual assessment of immunohistochemistry biomarkers by pathologists. However, pathology services face mounting pressure as diagnostic demand increases and workforce decreases.
Digital pathology and artificial intelligence have the potential to streamline the diagnostic workflow thereby improving pathologists’ workload, accelerating turn-around-times and facilitating...
The new challenge is the usage of in silico methods in the field of
nanotechnology. Nanotechnology is an innovative science that involves
the designing, characterization, production and use of structures by
controlling their shape and size on a nanometric scale (from 1 to 100
nanometers).
Those aspects which affected attractiveness and have
caused more and...
There are a number of obstacles confronting today’s clinical trial research field:• Failure to accrue sufficient participants. Protocols designed without the benefit of real data to verify their feasibility have resulted in avoidable amendments and delays. • Flat to declining grant funding. More sites are competing for a static/decreasing...
I would like to find partners for co-operation + provide information about new tools which can be used for protein analysis and drug design.
We have developed a new tool for analysis of the MD simulations, which can contribute significantly to both protein functionality description and identification of crucial interactions...